Reach Us +1-504-608-239
Editor - Massimo Libra | University of Catania | 19090
ISSN: 2577-0535

Journal of Cancer Clinical Trials
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Massimo Libra

Massimo Libra
Massimo Libra
Associated Professor
University of Catania
University of Catania


Dr. Massimo Libra is associated professor of general pathology at the Department of Biomedical and Biotechnological Sciences, School of Medicine, University of Catania (Catania, Italy). He is director of the Translational Oncology & Functional Genomics Laboratory at the same Department. Dr. Massimo Libra received his M.D. degree from the University of Catania in 1995. Dr. Libra was a post-fellow at the National Cancer Institute in Aviano (Italy) during the Specialization in Oncology. In 2002, he received his Ph.D. degree in Oncology from the University of Catania. He was visiting scientist at the UCLA and East Carolina University. His research is focused on defining the molecular mechanisms involved in the genesis and progression of tumors and the identification of new elements for a more effective diagnosis, prognosis and treatment of cancer. In details, he studies the activation of Ras-Raf-MEK-ERK-MAPK and PI3K/PTEN/AKT/mTOR pathways and their pharmacological targeting, the cross-talk between the p53 pathway and other pathways (Yin Yang 1, Stathmin), associated with the development of cancer, the study of the tumor microenvironment (NGAL, OPN, MMPs, cytokines).

Research Interest

Molecular mechanisms involved in the genesis and progression of tumors Identification of new elements for a more effective diagnosis, prognosis and treatment of cancer Activation of Ras-Raf-MEK-ERK-MAPK PI3K/PTEN/AKT/mTOR pathways Study of the tumor microenvironment

Global Speakers in the subject

Global Experts in the subject

Leave Your Message 24x7